Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Center Study of Eculizumab in Patients With Generalized Myasthenia Gravis (gMG) Who Have Moderate to Severe Muscle Weakness Despite Treatment With Immunosuppressants
Conditions
Interventions
eculizumab
Placebo
Locations
25
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of California, Irvine
Orange, California, United States
University of California - Davis
Sacramento, California, United States
University of Florida & Shands Neuroscience Institute
Jacksonville, Florida, United States
Emory University
Atlanta, Georgia, United States
Wishard Hospital
Indianapolis, Indiana, United States
Start Date
October 1, 2008
Primary Completion Date
March 1, 2011
Completion Date
July 1, 2011
Last Updated
September 24, 2019
NCT06312644
NCT06754020
NCT07089121
NCT07247279
NCT07246564
NCT07470151
Lead Sponsor
Alexion Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions